EFFECT OF MYCOPHENOLATE MOFETIL ON THE HEMATOPOIETIC SYSTEM IN RENAL TRANSPLANT RECIPIENTS
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: SPASIć, Ana (Faculty of Medicine, University of Niš, Niš, Serbia, Department of Pharmacy, Niš, Serbia)
- Co-author(s): Ana Spasić
Mycophenolate mofetil (MMF) is an immunosuppressive drug widely used after renal transplantation. Although MMF is generally well tolerated, it frequently causes hematological toxicity.
The dose of MMF varied from 0.50 to 2.00 g/day. The concentration of MPA was determined using the HPLC method for 116 renal transplant recipients during the late.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.